Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes

Metabolism

Volumn 39, Issue 6, 1990, Pages 598-604

  Ruotolo, Giacomo ^a,b,c   Micossi, Piero ^a,b,c   Galimberti, Gabriella ^a,b,c   Librenti, Maria Cristina ^a,b,c   Petrella, Giovanna ^a,b,c   Marcovina, Santica ^a,b,c   Pozza, Guido ^a,b,c   Howard, Barbara V ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Washington Hospital Center   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; FATTY ACID; INSULIN; RADIOISOTOPE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; APOLIPOPROTEINS B; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HUMAN; INFUSION PUMPS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INSULIN; KINETICS; LIPOPROTEINS; LIPOPROTEINS, LDL CHOLESTEROL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGE; TRIGLYCERIDES;

EID: 0025350262     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(90)90025-8     Document Type: Article

References (48)

1. Diabetes and cardiovascular risk factors: The Framingham study
2. The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics
3. Coronary heart disease risk and impaired glucose tolerance
4. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
5. Hyperinsulinemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview
6. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
7. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects
8. Overview of the association between insulin and atherosclerosis
9. Insulin treatment and diabetes: Half a century of therapeutic misadventure?
10. Insulin, glucagon and amino acids during glycemic control by the artificial pancreas in diabetic man
11. The metabolic and hormonal response to acute normoglycemia in type 1 (insulin-dependent) diabetes: Studies with a glucose controlled insulin infusion system (artificial endocrine pancreas)
12. Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs
13. Long-term continuous intraperitoneal insulin treatment in brittle diabetes
14. Free-insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration
15. Five-Day Programmed Intraperitoneal Insulin Delivery in Insulin-Dependent Diabetic Man*
16. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man
17. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: Comparison with intravenous and subcutaneous routes
18. Implanted constant basal rate insulin infusion devices for type 1 (insulin-dependent) diabetic patients
19. Lipoprotein lipase in diabetes
20. Diabetes, lipoproteins, and atherosclerosis
21. In vivo stimulation of low-density lipoprotein egradation by insulin
22. Chronic continuous intraperitoneal insulin infusion (CIPII) in type 1 diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII)
23. Effect of intraperitoneal insulin therapy on plasma lipids and apolipoproteins in type 1 diabetes
24. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample
25. Automated simultaneous cholesterol and triglyceride determination on the Auto Analyzer Instrument
26. Quantitative determination of serum triglycerides by use of enzymes
27. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B
28. Efficient trace-labelling of proteins with iodine
29. Influence of obesity on the metabolism of apolipoprotein B in humans
30. Very-low lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids
31. A microfluorometric method for the determination of free fatty acids in plasma
32. Determination of total serum insulin in insulin-treated diabetic patients
33. Protein measurement with folin phenol reagent
34. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
35. Development of an integrated model for analyses of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins
36. Plasma insulin and lipoprotein concentrations: an atherogenic association?
37. Hyperglycemia and plasma lipid levels: A prospective study of young insulin-dependent diabetic patients
38. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control
39. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy
40. Reappraisal of the role of insulin in hypertriglyceridemia
41. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes
42. The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus
43. Failure to achieve tight control of plasma cholesterol and apoprotein B with intraperitoneal insulin administration in type I diabetes
44. Portal ν peripheral hyperinsulinemia and very low density lipoprotein triglyceride kinetics
45. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism
46. Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes
47. Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects
48. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease